Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

19.4%

6 terminated/withdrawn out of 31 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

16%

5 trials in Phase 3/4

Results Transparency

48%

10 of 21 completed trials have results

Key Signals

3 recruiting10 with results

Enrollment Performance

Analytics

N/A
9(45.0%)
Phase 4
5(25.0%)
Phase 2
4(20.0%)
Phase 1
2(10.0%)
20Total
N/A(9)
Phase 4(5)
Phase 2(4)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (31)

Showing 20 of 31 trials
NCT03901521Enrolling By Invitation

Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository

Role: collaborator

NCT00792155Recruiting

Polycystic Kidney Disease Data Repository

Role: lead

NCT01109368Recruiting

The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository

Role: lead

NCT05540457Not ApplicableCompleted

Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis)

Role: lead

NCT01802034Recruiting

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

Role: lead

NCT01156428Completed

Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney Disease

Role: lead

NCT03567837Not ApplicableTerminated

Fructose-induced Hepatic De Novo Lipogenesis in Adolescents With Obesity

Role: lead

NCT04155216Not ApplicableCompleted

A Guided Meditation Program in Patients Undergoing Dialysis

Role: lead

NCT01562782Not ApplicableCompleted

Change of Fructose to Fat in South Asians

Role: lead

NCT03102632Not ApplicableCompleted

A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Kidney Disease

Role: lead

NCT03698877Completed

Procalcitonin and Brain Natriuretic Peptides in Patients With Chronic Kidney Disease.

Role: lead

NCT02161068Completed

Clinical Care of Autosomal Polycystic Kidney Disease: Retrospective Analysis and Prospective PKD Genotyping

Role: lead

NCT04143100Completed

Anxiety and Symptom Burden in Hemodialysis Patients

Role: lead

NCT01053013Phase 2Completed

Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal Cancer

Role: lead

NCT02046174Phase 2Completed

Open-Label Phase IIb Efficacy Trial of Cancer Macrobeads Compared to Best Supportive Care in Colorectal Cancer Patients

Role: lead

NCT03229265Phase 4Completed

Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving Patiromer

Role: lead

NCT02595723Phase 4Completed

Phenytoin for Memory Impairment Secondary to Megestrol

Role: collaborator

NCT00283075Phase 1Completed

Mouse Cancer Cell-containing Macrobeads in the Treatment of Human Cancer

Role: lead

NCT01174368Phase 2Completed

Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T

Role: lead

NCT01103778Phase 4Completed

Pilot Study of Velcade® in IgA Nephropathy

Role: lead